Current status of clinical background of patients with atrial fibrillation in a community-based survey: The Fushimi AF Registry

Journal of Cardiology

Volumn 61, Issue 4, 2013, Pages 260-266

  Akao, Masaharu ^a   Chun, Yeong Hwa ^b   Wada, Hiromichi ^a   Esato, Masahiro ^b   Hashimoto, Tetsuo ^b   Abe, Mitsuru ^a   Hasegawa, Koji ^a   Tsuji, Hikari ^c   Furuke, Keizo ^d  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b Ijinkai Takeda General Hospital   (Japan)

^c Tsuji Clinic   (Japan)

^d Furuke Clinic   (Japan)

Author keywords

Anticoagulants; Atrial fibrillation; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; AGED; ARTICLE; BODY WEIGHT; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIVATE HOSPITAL; REGISTER; URBAN POPULATION; WEIGHT;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; COMORBIDITY; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; STROKE; URBAN POPULATION; WARFARIN;

EID: 84875667596     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.12.002     Document Type: Article

References (21)

1. Kannel W.B., Wolf P.A., Benjamin E.J., Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998, 82:2-9.
2. Ohsawa M., Okayama A., Sakata K., Kato K., Itai K., Onoda T., Ueshima H. Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000. J Epidemiol 2005, 15:194-196.
3. Inoue H., Fujiki A., Origasa H., Ogawa S., Okumura K., Kubota I., Aizawa Y., Yamashita T., Atarashi H., Horie M., Ohe T., Doi Y., Shimizu A., Chishaki A., Saikawa T., et al. Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol 2009, 137:102-107.
4. Hart R.G., Benavente O., McBride R., Pearce L.A. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999, 131:492-501.
5. Connolly S.J., Ezekowitz M.D., Yusuf S., Eikelboom J., Oldgren J., Parekh A., Pogue J., Reilly P.A., Themeles E., Varrone J., Wang S., Alings M., Xavier D., Zhu J., Diaz R., et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009, 361:1139-1151.
6. Patel M.R., Mahaffey K.W., Garg J., Pan G., Singer D.E., Hacke W., Breithardt G., Halperin J.L., Hankey G.J., Piccini J.P., Becker R.C., Nessel C.C., Paolini J.F., Berkowitz S.D., Fox K.A., et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011, 365:883-891.
7. Granger C.B., Alexander J.H., McMurray J.J., Lopes R.D., Hylek E.M., Hanna M., Al-Khalidi H.R., Ansell J., Atar D., Avezum A., Bahit M.C., Diaz R., Easton J.D., Ezekowitz J.A., Flaker G., et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011, 365:981-992.
8. Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001, 285:2864-2870.
9. Lip G.Y., Nieuwlaat R., Pisters R., Lane D.A., Crijns H.J. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010, 137:263-272.
10. Atarashi H., Inoue H., Okumura K., Yamashita T., Kumagai N., Origasa H. Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry. Circ J 2011, 75:1328-1333.
11. Atarashi H., Inoue H., Okumura K., Yamashita T., Origasa H. Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation-the J-RHYTHM Registry study design. J Cardiol 2011, 57:95-99.
12. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): digest version. Circ J 2010, 74:2479-2500.
13. Ogawa S., Koretsune Y., Yasaka M., Aizawa Y., Atarashi H., Inoue H., Kamakura S., Kumagai K., Mitamura H., Okumura K., Sugi K., Yamashita T. Antithrombotic therapy in atrial fibrillation: evaluation and positioning of new oral anticoagulant agents. Circ J 2011, 75:1539-1547.
14. Sato H., Ishikawa K., Kitabatake A., Ogawa S., Maruyama Y., Yokota Y., Fukuyama T., Doi Y., Mochizuki S., Izumi T., Takekoshi N., Yoshida K., Hiramori K., Origasa H., Uchiyama S., et al. Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial. Stroke 2006, 37:447-451.
15. Hohnloser S.H., Pajitnev D., Pogue J., Healey J.S., Pfeffer M.A., Yusuf S., Connolly S.J. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W substudy. J Am Coll Cardiol 2007, 50:2156-2161.
16. Furusho H., Takamura M., Takata S., Sakagami S., Hirazawa M., Kato T., Murai H., Okajima M., Kaneko S. Current status of anticoagulation therapy for elderly atrial fibrillation patients in Japan: from Hokuriku atrial fibrillation trial. Circ J 2008, 72:2058-2061.
17. Nieuwlaat R., Capucci A., Camm A.J., Olsson S.B., Andresen D., Davies D.W., Cobbe S., Breithardt G., Le Heuzey J.Y., Prins M.H., Levy S., Crijns H.J. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005, 26:2422-2434.
18. Ogilvie I.M., Newton N., Welner S.A., Cowell W., Lip G.Y. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 2010, 123:638-645.
19. Waldo A.L., Becker R.C., Tapson V.F., Colgan K.J. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 2005, 46:1729-1736.
20. Gorin L., Fauchier L., Nonin E., Charbonnier B., Babuty D., Lip G.Y. Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project. Chest 2011, 140:911-917.
21. Yamashita T. Frontiers of anticoagulation therapy for atrial fibrillation. J Cardiol 2011, 58:1-5.